Respiratory Virus Vaccines Market In-depth Analysis, Business Strategies, and Growth Rate

Respiratory Virus Vaccines Market: Introduction

The global respiratory virus vaccines market was valued at US$ 2.6 Bn in 2019. It is projected to expand at a CAGR of ~8% from 2020 to 2030. A vaccine is a biological preparation that is used to provide acquired immunity against numerous harmful pathogens. It is administered in order to prevent the vulnerable population against specific disease. It contains an agent, i.e. bacteria or virus strain, which causes a particular disease in a weakened or killed form. In terms of type, the global respiratory virus vaccines market has been classified into inactivated/killed vaccines, live-attenuated vaccines, and recombinant vaccines. The inactivated/killed vaccines segment accounted for a prominent share of the global market in 2019. The segment is estimated to be driven by the launch of new vaccines and robust research programs for the development of inactivated vaccine for COVID-19. Based on route of administration, the global respiratory virus vaccines market has been categorized into intramuscular, intranasal, and subcutaneous. The intramuscular segment held a major share of the global market in 2019.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78499

In terms of indication, the global respiratory virus vaccines market has been classified into influenza, measles, mumps & rubella, coronavirus disease (COVID-19), and others. The influenza segment held a notable share of the global market in 2019. The segment is likely to be driven an increase in number of influenza patients and a rise in focus on vaccination programs for children. Based on age group, the global respiratory virus vaccines market has been divided into pediatric and adults. The pediatric segment accounted for a leading share of the global market in 2019. In terms of end user, the global respiratory virus vaccines market has been classified into physician's office, hospitals, clinics, pharmacies/stores, and others. The physician's office segment held a significant share of the global market in 2019.

Request a Sample of Respiratory Virus Vaccines Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78499

Respiratory Virus Vaccines Market: Prominent Regions

North America held a major share of the global respiratory virus vaccines market in 2019. Increase in demand for effective vaccination, rise in number of patients with influenza, and favourable government support for adult and pediatric vaccination are key factors driving the market in the region. According to the Centers for Disease Control and Prevention (CDC), seasonal influenza accounts for over 20,000 deaths in the U.S. each year. Europe held the second-largest share of the global respiratory virus vaccines market in 2019. The expansion of the respiratory virus vaccines market in the region can be attributed to increase in investment in R&D activities to develop vaccine against the novel coronavirus through partnerships between pharmaceutical companies.

Request for Analysis of COVID19 Impact on Respiratory Virus Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78499

Respiratory Virus Vaccines Market: Key Players

Leading players are expanding their footprint to strengthen their positions in the global respiratory virus vaccines market. The increase in adoption of inorganic strategies such as mergers & acquisition and new product development, promising drug candidates in pipeline for corona virus & respiratory syncytial virus (RSV), and rise in research & development efforts by major pharmaceutical companies are likely to offer significant opportunities in the global respiratory virus vaccines market. Key players operating in the global respiratory virus vaccines market include CSL Limited, Sanofi, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, and Sinovac Biotech Ltd.

Enquiry before Buying Respiratory Virus Vaccines Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=78499

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html

https://www.prnewswire.com/news-releases/medical-transcription-services-market-to-expand-at-cagr-of-5-during-forecast-period-observes-tmr-study-301482824.html

https://www.prnewswire.com/news-releases/corporate-wellness-market-to-expand-at-cagr-of-8-2-during-forecast-period-says-tmr-study-301486464.html

Contact Us

Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

This release was published on openPR.